|
||||||||||||||||||||||||||
| SEC Info℠ | | | Home | | | Search | | | My Interests | | | Help | | | Sign In | | | Please Sign In | |||||||
|
||||||||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 3/05/20 DNA Testing Centers Corp 10-K 12/31/18 38:1.6M Discount Edgar/FA |
Document/Exhibit Description Pages Size
1: 10-K Annual Report HTML 440K
2: EX-31.1 Certification -- §302 - SOA'02 HTML 18K
3: EX-31.2 Certification -- §302 - SOA'02 HTML 18K
4: EX-32.1 Certification -- §906 - SOA'02 HTML 14K
5: EX-32.2 Certification -- §906 - SOA'02 HTML 14K
15: R1 Document and Entity Information HTML 63K
30: R2 Consolidated balance sheets HTML 72K
36: R3 Consolidated balance sheets (Parenthetical) HTML 32K
23: R4 Consolidated statements of operations and HTML 60K
comprehensive loss
16: R5 Consolidated statements of stockholders' deficit HTML 33K
31: R6 Consolidated Statements of Cash Flows HTML 62K
37: R7 Nature of Operations and Continuance of Business HTML 18K
24: R8 Significant Accounting Policies HTML 41K
14: R9 Property and Equipment HTML 21K
28: R10 Related Party Transactions HTML 19K
32: R11 Common Stock HTML 17K
21: R12 Income Taxes HTML 32K
12: R13 Significant Accounting Policies (Policies) HTML 85K
29: R14 Significant Accounting Policies (Tables) HTML 14K
33: R15 Property and Equipment (Tables) HTML 21K
22: R16 Income Taxes (Tables) HTML 30K
13: R17 Nature of Operations and Continuance of Business HTML 24K
(Details Narrative)
27: R18 Significant Accounting Policies (Details) HTML 15K
34: R19 Property and Equipment (Details) HTML 25K
19: R20 Related Party Transactions (Details Narrative) HTML 27K
18: R21 Common Stock (Details Narrative) HTML 22K
26: R22 Income Taxes (Details) HTML 36K
38: R23 Income Taxes (Details 1) HTML 21K
20: R24 Income Taxes (Details Narrative) HTML 20K
35: XML IDEA XML File -- Filing Summary XML 58K
17: EXCEL IDEA Workbook of Financial Reports XLSX 29K
6: EX-101.INS XBRL Instance -- dnac-20181231 XML 301K
9: EX-101.CAL XBRL Calculations -- dnac-20181231_cal XML 35K
11: EX-101.DEF XBRL Definitions -- dnac-20181231_def XML 103K
8: EX-101.LAB XBRL Labels -- dnac-20181231_lab XML 328K
10: EX-101.PRE XBRL Presentations -- dnac-20181231_pre XML 269K
7: EX-101.SCH XBRL Schema -- dnac-20181231 XSD 56K
25: ZIP XBRL Zipped Folder -- 0001477932-20-001058-xbrl Zip 51K
| 1. | I have reviewed this Annual Report on Form 10-K of DNA Testing Centers Corp.; |
| 2. | Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; |
| 3. | Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report; |
| 4. | The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have: |
| a. | Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared; | |
| b. | Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles; | |
| c. | Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and | |
| d. | Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and |
| 5. | The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions): |
| a. | All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and | |
| b. | Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting. |
| Date: March 4, 2020 | /s/ Barjinder Sohal | ||
| Barjinder Sohal | |||
| President, Chief Executive Officer and Director | |||
| (Principal Financial Officer and Principal Accounting Officer) |
| This ‘10-K’ Filing | Date | Other Filings | ||
|---|---|---|---|---|
 | ||||
| Filed as of: | 3/5/20 | None on these Dates | ||
| Filed on: | 3/4/20 | |||
| For Period end: | 12/31/18 | |||
| List all Filings | ||||